Emerging Approaches in AMD and DME: A Case-Based Discussion : Episode 3

Commentary

Video

October 11, 2023

Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

Author(s):

Moritz Pettenkofer, MD

Moritz Pettenkofer, MD, presents a case of a 75-year-old male patient with nARMD who has had 53 injections of anti-VEGF therapy over 4 years.

EP: 1.Overview of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

EP: 2.Single-dose faricimab in treatment-experiences eyes with nARMD: Case 1

EP: 3.Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

Related Videos

Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital

Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates

Diana V. Do, MD: 3-Year PHOTON Data on Aflibercept 8 mg for DME | Image Credit: Stanford University

Eric W Schneider, MD: Comparing AI-Based Home OCT to In-Office OCT Scans | Image Credit: Tennessee Retina

Matthew Cunningham, MD: 1-Year ELEVATUM Results Target Disparities in DME | Image Credit: Florida Retina Institute

Dennis M. Marcus, MD , an expert on neovascular AMD

Dennis M. Marcus, MD , an expert on neovascular AMD

HCPLive Five at ASRS 2024 | Image Credit: HCPLive

Jordana Fein, MD: Pre-Dose IOP Outcomes After Aflibercept 8 mg for DME | Image Credit: LinkedIn

Diana Do, MD: Impact of Baseline BCVA on Aflibercept 8 mg Outcomes in DME | Image Credit: Stanford University

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.